What one share of Connect Biopharma Holdings Limited holds
Connect Biopharma, headquartered in San Diego, California, is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (“COPD”). The Company is advancing rademikibart, a next-generation, potentially best-in-class antibody designed to target interleukin-4-receptor alpha (“IL-4Rα”).
Connect Biopharma Holdings Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.05 |
|---|---|
| Profit | −$1.19 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.05 |
| Cash and investments | $0.43 |
| Book value | $0.43 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$1.13 | $0.00 | −$0.87 | — | $1.84 |
| 2024 | — | −$0.28 | $0.01 | −$0.44 | — | $1.67 |
| 2025 | $0.00 | −$1.00 | $0.01 | −$0.93 | — | $0.74 |
Common questions about Connect Biopharma Holdings Limited
How much does one share of Connect Biopharma Holdings Limited earn?
Over the last 12 months, Connect Biopharma Holdings Limited lost $1.19 for each share on $0.05 of sales.
Does Connect Biopharma Holdings Limited pay a dividend?
Connect Biopharma Holdings Limited didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Connect Biopharma Holdings Limited’s book value per share?
Connect Biopharma Holdings Limited’s book value is $0.43 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Connect Biopharma Holdings Limited have?
Each share of Connect Biopharma Holdings Limited has $0.43 of cash and investments, as of June 30, 2026.
What is Connect Biopharma Holdings Limited’s free cash flow per share?
−$1.05 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.